Progyny, Inc. Share Price

Equities

PGNY

US74340E1038

Managed Healthcare

Market Closed - Nasdaq 01:30:00 14/06/2024 am IST 5-day change 1st Jan Change
27.33 USD -1.41% Intraday chart for Progyny, Inc. -2.15% -26.49%
Sales 2024 * 123.88Cr 10TCr Sales 2025 * 145.42Cr 12TCr Capitalization 260.24Cr 22TCr
Net income 2024 * 7.2Cr 601.42Cr Net income 2025 * 9.8Cr 818.59Cr EV / Sales 2024 * 1.88 x
Net cash position 2024 * 27Cr 2.24TCr Net cash position 2025 * 48Cr 4.01TCr EV / Sales 2025 * 1.46 x
P/E ratio 2024 *
38.2 x
P/E ratio 2025 *
28.4 x
Employees 565
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.41%
1 week-2.15%
Current month+1.41%
1 month-0.26%
3 months-25.51%
6 months-24.34%
Current year-26.49%
More quotes
1 week
26.77
Extreme 26.77
28.89
1 month
25.63
Extreme 25.625
28.89
Current year
23.90
Extreme 23.9
42.08
1 year
23.90
Extreme 23.9
44.95
3 years
23.90
Extreme 23.9
68.32
5 years
13.29
Extreme 13.29
68.32
10 years
13.29
Extreme 13.29
68.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/17/01
President 47 01/21/01
Director of Finance/CFO 58 01/19/01
Members of the board TitleAgeSince
Director/Board Member 67 01/10/01
Director/Board Member 61 01/19/01
Director/Board Member 49 16/16/16
More insiders
Date Price Change Volume
13/24/13 27.33 -1.41% 664,108
12/24/12 27.72 -1.39% 1,106,683
11/24/11 28.11 +1.01% 739,486
10/24/10 27.83 +0.83% 665,746
07/24/07 27.6 -1.18% 555,151

Delayed Quote Nasdaq, June 14, 2024 at 01:30 am IST

More quotes
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
27.33 USD
Average target price
38 USD
Spread / Average Target
+39.04%
Consensus